Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...

PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

(MENAFN- Mid-East Info) M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC ... Vice Chairman and President of MENA, said:“We are proud to sign ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: scielo@scielo.org ...

(MENAFN- AETOSWire) Hikma Pharmaceuticals PLC (Hikma), the multinational ... Mazen Darwazah, Hikma's Executive Vice Chairman and President of MENA, said: “We are proud to sign this strategic ...

The introduction of the Shield™ test for colorectal cancer screening marks a transformative step in advancing precision and ...

Shares of Hikma Pharmaceuticals PLC HIK advanced 1.63% to £22.48 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0. ...

A new wave of hope is sweeping across Europe and MENA for millions of cancer patients seeking affordable and effective treatment options. The rise of generic oncology drugs is offering a much-needed ...

Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that the sales in 2024 ...